20770-57-4

Upstream product

• 87-89-8 D-myo-inositol 
• 98-88-4 benzoyl chloride 
• 551-72-4 inositol 
• 99044-47-0 1,2,3,4,5-penta-O-benzoyl-6-O-benzyl-myo-inositol 
• 18391-42-9 D-1,2,4,5,6-penta-O-benzoyl-3-O-methyl-chiro-inositol 
• 73763-43-6 D-1,2,4,5,6-penta-O-benzoyl-3-O-formyl-chiro-inositol 
• 6770-74-7 1L-2,3,4,5,6-Penta-O-benzoyl-1-O--chiro-inosit 
• 106600-11-7 2,3,4,5,6-penta-O-benzyl-scyllo-inosose 

Downstream Products

• 122540-97-0 2-Acetyl-1,3,4,5,6-pentakisbenzoylmyoinositol 
• 106600-11-7 2,3,4,5,6-penta-O-benzyl-scyllo-inosose 

Relevant academic research and scientific papers

The oxidation of partially acylated myoinositols

1,3,4,6-Tetrakis-and 1,3,4,5,6-pentakis-acylmyoinositols are obtained by the controlled catalyzed acylation of myoinositol. The extent of the substitution depends both on the reaction conditions and the structure of the acylating agent, including steric f

SYNTHESIS OF 1D- AND 1L-4-O-BENZYL-myo-INOSITOL, 1D-4-O-α-L-FUCOPYRANOSYL-myo-INOSITOL (IDENTICAL TO A NATURAL GLYCOSIDE), AND 1L-4-O-α-L-FUCOPYRANOSYL-myo-INOSITOL

The α-L-fucopyranosyl-myo-inositol isolated from human urine has been proved to be the 1D-4-O-myo-inositol derivative by unambiguous syntheses of this substance and of the diastereomeric 1L-4-O-myo-inositol derivative.The chiral penta-O-benzoyl-myo-inosit